Tygh Capital Management’s Evolent Health EVH Stock Holding History

Tygh Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-208,852	Closed	-$2.63M	–	83
2019 Q1	$2.63M	Sell	208,852 -128,667	-38%	-$2.04M	0.46%	72
2018 Q4	$6.73M	Buy	337,519 +158,482	+89%	+$3.67M	1.41%	29
2018 Q3	$5.08M	Buy	+179,037	New	+$4.27M	0.83%	54
2017 Q4	–	Sell	-297,994	Closed	-$5.3M	–	100
2017 Q3	$5.3M	Buy	297,994 +130,979	+78%	+$2.7M	1.06%	49
2017 Q2	$4.23M	Sell	167,015 -147,927	-47%	-$3.56M	0.96%	59
2017 Q1	$7.02M	Buy	314,942 +209,876	+200%	+$4.03M	1.64%	9
2016 Q4	$1.55M	Buy	+105,066	New	+$2.07M	0.39%	86

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Tygh Capital Management's EVH Position: Q2 2019 in Review

Tygh Capital Management sold out of Evolent Health (EVH) in Q2 2019, closing a stake of 208,852 shares — an estimated $2.63M sold.

Tygh Capital Management first reported a position in EVH in Q4 2016 and held it in 7 quarters. The position peaked at $7.02M in Q1 2017. 183 funds tracked by Wall St. Rank hold EVH as of Q2 2019.

Tygh Capital Management reported no remaining Evolent Health position as of Q2 2019 after selling out during the quarter.
Tygh Capital Management sold 208,852 Evolent Health shares in Q2 2019, an estimated $2.63M.
Tygh Capital Management first reported a position in Evolent Health in Q4 2016 and held it in 7 quarters.
Tygh Capital Management's Evolent Health position peaked at $7.02M in Q1 2017.
183 funds tracked by Wall St. Rank held Evolent Health as of Q2 2019.

Based on Tygh Capital Management's 13F filing for Q2 2019, filed 5 Aug 2019.